Protagenic Therapeutics earnings were -$6.4M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest PTIX earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$1.6M, down 6.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PTIX reported annual earnings of -$5.0M, with 40.6% growth. The next PTIX earnings date is Nov 12, 2024.
Protagenic Therapeutics Earnings Reports & History FAQ
What were Protagenic Therapeutics's earnings last quarter?
On PTIX's earnings call on Invalid Date, Protagenic Therapeutics (NASDAQ: PTIX) reported Q2 2024 earnings per share (EPS) of -$0.36, up 28.57% year over year. Total PTIX earnings for the quarter were -$1.61 million. In the same quarter last year, Protagenic Therapeutics's earnings per share (EPS) was -$0.28.
When does Protagenic Therapeutics report earnings?
The next PTIX earnings call is Invalid Date. Add PTIX to your watchlist to be reminded of Protagenic Therapeutics's next earnings date.
What was PTIX's earnings growth in the past year?
As of Protagenic Therapeutics's earnings date in Invalid Date, Protagenic Therapeutics's earnings has grown year over year. PTIX earnings in the past year totalled -$6.40 million.
Is Protagenic Therapeutics profitable or losing money?
As of the last Protagenic Therapeutics earnings report, Protagenic Therapeutics is currently losing money. Protagenic Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$6.40 million, a 85.38% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.